Are Options Traders Bullish on ARAV?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ARAV

Versartis, Inc. is an endocrine-focused biopharmaceutical company initially developing somavaratan, a novel, long-acting form of recombinant human growth hormone in late-stage clinical trials for the treatment of GHD in children and adults. Somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving adherence and, therefore, treatment outcomes.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ARAV is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 15.3 B 1.53181E+10 3,420 3420 0.0% 0 10 K 9796
IWC iShares Microcap ETF 912.4 M 9.12448E+08 1,449 1449 0.01% 0.0001 91 K 90751
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.9 B 1.9E+09 1,029 1029 0.0% 1.99836E-05 36 K 36421
WMCR Invesco Wilshire Micro-Cap ETF 25.9 M 2.59E+07 1,085 1085 0.03% 0.00029 7 K 7384

Wait, Before You Leave...